Request Deal Involvement
Orifarm Group completed the acquisition of the OTC and non-core assets of Takeda Pharmaceutical for $670m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Kromann Reumert
financial advisors
Danske Bank
accounting advisors
Ernst & Young
legal advisors
Wardynski & Partners
pr advisors
Sard Verbinnen & Co
financial advisors
JP Morgan
legal advisors
White & Case
or
Principals
target
TAKEDA PHARMACEUTICAL COMPANY LIMITED (OTC ASSETS)
bidder
ORIFARM GROUP
vendor
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite